Discover how Urenco Isotopes, a European manufacturer, supplies high purity isotopes for healthcare, industry, and research, enabling breakthroughs through advanced enrichment technologies and sustainable innovation.
Whilst the Urenco Group is widely recognised for enriching uranium for civil nuclear power, its Urenco Isotopes business unit operates in a distinct yet equally vital field. Based in Almelo, the Netherlands, Urenco Isotopes supplies a diverse portfolio of stable isotopes in various chemical forms, leveraging Urenco’s advanced centrifuge technology. These products support applications ranging from scientific research and complex manufacturing to cancer treatment and diagnostic imaging.
In this session, Wietse Smit introduces Urenco Isotopes as a European manufacturer, highlighting its history, advanced enrichment technologies, and growing isotope portfolio. The presentation explores key applications across healthcare, industry, and research including diagnostics, cancer therapy, quantum computing, and emerging theranostics, while outlining future innovation plans and capacity growth. Attendees will gain valuable insights into the technical processes, logistics considerations, and real-world applications that make these isotopes globally indispensable.
Speaker Bio:
This webinar is presented by Wietse Smit and Alice Field.
Wietse is a Development Engineer with 11 years of experience within the Urenco Isotopes R&D department. His main focus lies on product development and the expansion of the current Isotopes portfolio.
Alice is a commercial professional with four years’ experience in the nuclear industry, spanning decommissioning and isotopes. Through roles in business development and marketing and communications, she now specialises in promoting and showcasing Urenco Isotope’s product portfolio and capabilities.
When: Friday 10 July 12:00 to 13:00
Where: Online via Teams (Access will be provided in the registration confirmation email you will receive)
Registration deadline: Friday 10 July 12:00
